Nasdaq: DSGN
Design Therapeutics insiders
The officers, directors and 10% owners of Design Therapeutics, Inc. who hold the most stock, valued at the live DSGN price.
$9.32
DSGN today −$150K (−1.58%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 2
- Their DSGN stock
- $61.4M
- Market value
- $615M
- Held by ranked insiders
- 9.99%
Insiders by value of DSGN holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | SR One Capital Partners I, LP | 10% owner | 6,526,476 | $60.8M | 9.89% | Corporate |
| 2 | John P. Schmid | Director | 66,795 | $623K | 0.10% | 11064th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Design Therapeutics; see each profile for the filing.